This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rao, D. S. Articles by Parfitt, A. M. Search for Related Content PubMed PubMed Citation Articles by Rao, D. S. Articles by Parfitt, A. M.

Effect of Vitamin D Nutrition on Parathyroid Adenoma Weight: Pathogenetic and Clinical Implications¹

Division of Bone and Mineral Metabolism, Department of Medicine (D.S.R., M.H., E.R.P.), Departments of Biostatistics (G.W.D.), Pathology (M.W.L.), and Surgery (M.R.A., G.B.T.), Henry Ford Health System, Detroit, Michigan 48202; and Division of Endocrinology and Center for Osteoporosis and Metabolic Bone Disease, University of Arkansas for Medical Sciences (A.M.P.), Little Rock, Arkansas 72205

Address all correspondence and requests for reprints to: Dr. D. Sudhaker Rao, Division of Bone and Mineral Metabolism, Henry Ford Health System, 2799 West Grand Boulevard, K-16, E-1607, Detroit, Michigan 48202-2689. E-mail: danrao50{at}hotmail.com

In primary hyperparathyroidism, adenoma size is a major determinant of disease severity and manner of presentation, but the reason for the large variation in size (>100-fold) is unknown. One factor could be the level of vitamin D nutrition, because in India, where vitamin D deficiency is endemic, adenomas are larger and the disease more severe than in the U.S. Accordingly, we determined the relationship between vitamin D nutrition, as measured by serum levels of 25-hydroxyvitamin D (25OHD), and parathyroid gland weight, expressed on a logarithmic scale, in 148 U.S. patients with primary hyperparathyroidism.

A significant inverse relationship was found between log gland weight as dependent variable and serum 25OHD as independent variable (r = -0.365; P < 0.0001). The only other influence on gland weight was a weak inverse correlation with age. Log gland weight as an independent variable was significantly related to adjusted calcium, PTH, and alkaline phosphatase (AP) as dependent variables. In 51 patients with serum 25OHD levels less than 15 ng/mL, gland weight, PTH, AP, and adjusted calcium were each significantly higher than in 97 patients with 25OHD levels of 15 ng/mL or more, but 1,25-dihydroxyvitamin D levels were similarly increased in both groups. In the former group the response of adjusted calcium to PTH was blunted, and the response of AP was enhanced, based on significant differences in regression slopes (P = 0.0004 and 0.0022, respectively).

Suboptimal vitamin D nutrition stimulates parathyroid adenoma growth by a mechanism unrelated to hypocalcemia or 1,25-dihydroxyvitamin D deficiency and reduces the calcemic response to PTH, so that a higher PTH level and more parathyroid cells are needed to raise the patient’s serum calcium to the level corresponding to the increased set-point that is characteristic of the disease. Improved vitamin D nutrition in the population is partly, perhaps largely, responsible for the historical changes in disease severity and manner of presentation that have occurred over the last 50 yr.

This article has been cited by other articles:

				J. K Y Lam, K. S L Lam, K. C B Tan, W.-S. Chow, A. W K Tso, and A. W C Kung A woman with hypophosphataemia and raised alkaline phosphatase BMJ, January 20, 2010; 340(jan20_1): b5564 - b5564. [Full Text]

				J R Tucci Vitamin D therapy in patients with primary hyperparathyroidism and hypovitaminosis D Eur. J. Endocrinol., July 1, 2009; 161(1): 189 - 193. [Abstract] [Full Text] [PDF]

				R. Eastell, A. Arnold, M. L. Brandi, E. M. Brown, P. D'Amour, D. A. Hanley, D. S. Rao, M. R. Rubin, D. Goltzman, S. J. Silverberg, et al. Diagnosis of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Third International Workshop J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 340 - 350. [Abstract] [Full Text] [PDF]

				P Iglesias and J J Diez Current treatments in the management of patients with primary hyperparathyroidism Postgrad. Med. J., January 1, 2009; 85(999): 15 - 23. [Abstract] [Full Text] [PDF]

				E. Kandil, A. P. Tufaro, K. A. Carson, F. Lin, H. Somervell, T. Farrag, A. Dackiw, M. Zeiger, and R. P. Tufano Correlation of Plasma 25-Hydroxyvitamin D Levels With Severity of Primary Hyperparathyroidism and Likelihood of Parathyroid Adenoma Localization on Sestamibi Scan Arch Otolaryngol Head Neck Surg, October 1, 2008; 134(10): 1071 - 1075. [Abstract] [Full Text] [PDF]

				G Priya, V P Jyotsna, N Gupta, S Chumber, C S Bal, A K Karak, A Seth, and A C Ammini Clinical and laboratory profile of primary hyperparathyroidism in India Postgrad. Med. J., January 1, 2008; 84(987): 34 - 39. [Abstract] [Full Text] [PDF]

				A. J. Felsenfeld, M. Rodriguez, and E. Aguilera-Tejero Dynamics of Parathyroid Hormone Secretion in Health and Secondary Hyperparathyroidism Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1283 - 1305. [Abstract] [Full Text] [PDF]

				K. Zajickova, J. Vrbikova, L. Canaff, P. D. Pawelek, D. Goltzman, and G. N. Hendy Identification and Functional Characterization of a Novel Mutation in the Calcium-Sensing Receptor Gene in Familial Hypocalciuric Hypercalcemia: Modulation of Clinical Severity by Vitamin D Status J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2616 - 2623. [Abstract] [Full Text] [PDF]

				B Moosgaard, P Vestergaard, L Heickendorff, F Melsen, P Christiansen, and L Mosekilde Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study. Eur. J. Endocrinol., August 1, 2006; 155(2): 237 - 244. [Abstract] [Full Text] [PDF]

				M. Kammori, T. Fukami, T. Ogawa, E.-i. Tsuji, K. Takubo, J. Nakajima, and M. Kaminishi Giant mediastinal cystic parathyroid adenoma. J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1635 - 1636. [Full Text] [PDF]

				D. Maggio, A. Cherubini, F. Lauretani, R. C. Russo, B. Bartali, M. Pierandrei, C. Ruggiero, M. C. Macchiarulo, R. Giorgino, S. Minisola, et al. 25(OH)D Serum Levels Decline With Age Earlier in Women Than in Men and Less Efficiently Prevent Compensatory Hyperparathyroidism in Older Adults J Gerontol A Biol Sci Med Sci, November 1, 2005; 60(11): 1414 - 1419. [Abstract] [Full Text] [PDF]

				A. Grey, J. Lucas, A. Horne, G. Gamble, J. S. Davidson, and I. R. Reid Vitamin D Repletion in Patients with Primary Hyperparathyroidism and Coexistent Vitamin D Insufficiency J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2122 - 2126. [Abstract] [Full Text] [PDF]

				N. Garcia de la Torre, I. Buley, J. A. H. Wass, D. G. Jackson, and H. E. Turner Angiogenesis and Lymphangiogenesis in Parathyroid Proliferative Lesions J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2890 - 2896. [Abstract] [Full Text] [PDF]

				G. Maruani, A. Hertig, M. Paillard, and P. Houillier Normocalcemic Primary Hyperparathyroidism: Evidence for a Generalized Target-Tissue Resistance to Parathyroid Hormone J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4641 - 4648. [Abstract] [Full Text] [PDF]

				R. Vieth, Y. Ladak, and P. G. Walfish Age-Related Changes in the 25-Hydroxyvitamin D Versus Parathyroid Hormone Relationship Suggest a Different Reason Why Older Adults Require More Vitamin D J. Clin. Endocrinol. Metab., January 1, 2003; 88(1): 185 - 191. [Abstract] [Full Text] [PDF]

				U. Segersten, P. Correa, M. Hewison, P. Hellman, H. Dralle, T. Carling, G. Akerstrom, and G. Westin 25-Hydroxyvitamin D3-1{alpha}-Hydroxylase Expression in Normal and Pathological Parathyroid Glands J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2967 - 2972. [Abstract] [Full Text] [PDF]

				T. Carling Vitamin D Levels and Primary Hyperparathyroidism J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2328a - 2328. [Full Text]